2026 Global: Airway Stent/Lung Stent Market-Competitive Review (2032) report
Description
The 2026 Global: Airway Stent/Lung Stent Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for airway stent/lung stent market by geography and historical trend. The scope of the report extends to sizing of the airway stent/lung stent market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Boston Scientific Corporation, Taewoong Medical Co., Ltd., Micro‑Tech (Nanjing) Co., Ltd., Cook Group, Merit Medical Systems, Novatech SA, Efer Endoscopy, ENDO‑FLEX GmbH, Bess Medizintechnik (Bess AG), and E. Benson Hood Laboratories are widely recognized as ten major companies in the airway stent/lung stent market based on industry reports and market analyses. Boston Scientific holds a leading position globally with an extensive product portfolio and broad geographic presence that have driven market leadership in airway stents. Taewoong Medical, a South Korean developer, is noted for its specialized airway stent designs and strategic distribution partnerships that expanded its presence in key markets. Micro‑Tech (Nanjing) has grown through product development and international expansion including a U.S. subsidiary, positioning it as a major supplier of endobronchial and tracheal stents. Cook Group and Merit Medical Systems, both U.S.-based, contribute significant catalogues of minimally invasive devices and distribution networks that support clinical adoption of airway stents across interventional pulmonology and thoracic surgery.
Novatech SA and Efer Endoscopy, European companies, are important players with device portfolios and regulatory-compliant manufacturing that support their presence in France and broader European and international markets. ENDO‑FLEX GmbH, headquartered in Germany, supplies silicone and hybrid airway stents and is recognized for customization and quality manufacturing that meet varied clinical needs across hospitals and specialist centers. Bess Medizintechnik (Bess AG) and E. Benson Hood Laboratories add depth to the market through niche product offerings and regional penetration; Bess AG provides stent systems and accessories with a European footprint while E. Benson Hood Laboratories supplies medical devices and components to support airway management in the U.S. market. Together these companies represent a mix of multinational corporations and specialized manufacturers whose combined activities—product innovation, regulatory approvals, distribution agreements, and localized manufacturing—shape competition and availability of airway and lung stents worldwide.
Market reports consistently list additional manufacturers active in the sector (for example, Standard Sci. Tech, Stening SRL, Boston Medical Products, and others), indicating the market’s moderate concentration with several leading firms and a longer tail of regional specialists. Recent strategic moves highlighted in industry analyses include distribution partnerships, subsidiary launches, and collaborative agreements intended to accelerate market access and broaden device portfolios, illustrating how companies seek to balance regulatory compliance with innovation to meet clinician needs in interventional pulmonology and thoracic oncology. These dynamics—leadership by established medical device firms, regional specialization by European and Asian manufacturers, and partnership-driven expansion—define the competitive landscape for airway and lung stents as reported in current market research.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for airway stent/lung stent market by geography and historical trend. The scope of the report extends to sizing of the airway stent/lung stent market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Boston Scientific Corporation, Taewoong Medical Co., Ltd., Micro‑Tech (Nanjing) Co., Ltd., Cook Group, Merit Medical Systems, Novatech SA, Efer Endoscopy, ENDO‑FLEX GmbH, Bess Medizintechnik (Bess AG), and E. Benson Hood Laboratories are widely recognized as ten major companies in the airway stent/lung stent market based on industry reports and market analyses. Boston Scientific holds a leading position globally with an extensive product portfolio and broad geographic presence that have driven market leadership in airway stents. Taewoong Medical, a South Korean developer, is noted for its specialized airway stent designs and strategic distribution partnerships that expanded its presence in key markets. Micro‑Tech (Nanjing) has grown through product development and international expansion including a U.S. subsidiary, positioning it as a major supplier of endobronchial and tracheal stents. Cook Group and Merit Medical Systems, both U.S.-based, contribute significant catalogues of minimally invasive devices and distribution networks that support clinical adoption of airway stents across interventional pulmonology and thoracic surgery.
Novatech SA and Efer Endoscopy, European companies, are important players with device portfolios and regulatory-compliant manufacturing that support their presence in France and broader European and international markets. ENDO‑FLEX GmbH, headquartered in Germany, supplies silicone and hybrid airway stents and is recognized for customization and quality manufacturing that meet varied clinical needs across hospitals and specialist centers. Bess Medizintechnik (Bess AG) and E. Benson Hood Laboratories add depth to the market through niche product offerings and regional penetration; Bess AG provides stent systems and accessories with a European footprint while E. Benson Hood Laboratories supplies medical devices and components to support airway management in the U.S. market. Together these companies represent a mix of multinational corporations and specialized manufacturers whose combined activities—product innovation, regulatory approvals, distribution agreements, and localized manufacturing—shape competition and availability of airway and lung stents worldwide.
Market reports consistently list additional manufacturers active in the sector (for example, Standard Sci. Tech, Stening SRL, Boston Medical Products, and others), indicating the market’s moderate concentration with several leading firms and a longer tail of regional specialists. Recent strategic moves highlighted in industry analyses include distribution partnerships, subsidiary launches, and collaborative agreements intended to accelerate market access and broaden device portfolios, illustrating how companies seek to balance regulatory compliance with innovation to meet clinician needs in interventional pulmonology and thoracic oncology. These dynamics—leadership by established medical device firms, regional specialization by European and Asian manufacturers, and partnership-driven expansion—define the competitive landscape for airway and lung stents as reported in current market research.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.